Intra-Cellular Therapies Inc Sustainability Reports
A biopharmaceutical company that discovers, clinically develops, and commercializes small molecule drugs for neuropsychiatric and neurological disorders.
Sector: Manufacturing
Country: United States
Exchange: Unlisted
LEI: 5299002U2KGF193IJA20
FIGI: BBG0026ZFZD3
1 reports from 2023 to 2023
